Meeting
2016 Genitourinary Cancers Symposium
Molecular profiling of non-urothelial bladder cancer: Adenocarcinoma and squamous cell carcinoma.
Authors
Daniel M. Geynisman
Fox Chase Cancer Center, Philadelphia, PA
Daniel M. Geynisman , David Arguello , Sandeep K. Reddy , Zoran Gatalica
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer; Urothelial Carcinoma; Penile, Urethral, and Testicular Cancers
Track
Urothelial Carcinoma,Prostate Cancer,Penile, Urethral, and Testicular Cancers
Sub Track
Urothelial Carcinoma
Citation
J Clin Oncol 34, 2016 (suppl 2S; abstr 423)
DOI
10.1200/jco.2016.34.2_suppl.423
Abstract #
423
Poster Bd #
H16
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Seventeen percent of NGS 50 gene panel variants are not expressed in RNAseq.
First Author: Razelle Kurzrock
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of esophageal cancer: Adenocarcinoma vs. squamous cell carcinomas and impact on outcome.
First Author: Mohamed E. Salem
First Author: Jue Wang
Poster
2019 Genitourinary Cancers Symposium
Non-urothelial bladder cancer: Genomic alterations and patient outcomes.
First Author: Fern Anari